Article Information
History
- July 2, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- David Emes, MSc*,1,
- Anke Hüls, PhD MSc*,2,
- Nicole Baumer, MD3,
- Mara Dierssen, MD PhD4,
- Shiela Puri, MBBS5,
- Lauren Russel, MPH6,
- Stephanie L. Sherman, PhD7,
- Andre Strydom, MD8,
- Stefania Bargagna, MD9,
- Ana Cláudia Brandão, MD10,
- Alberto C.S. Costa, MD PhD11,
- Brian Allen Chicoine, MD12,
- Sujay Ghosh, PhD13,
- Anne-Sophie Rebillat, MD14,
- Giuseppina Sgandurra, MD15,
- Diletta Valentini, MD16,
- Tilman R. Rohrer, MD PhD17,
- Johannes Levin, MD18,
- Monica Lakhanpaul, MD**,19,
- The Trisomy 21 Research Society COVID-19 Initiative
- 1Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK
- 2Department of Epidemiology and Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
- 3Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA
- 4Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Doctor Aiguader 88,Barcelona, Spain. Universitat Pompeu Fabra (UPF), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain
- 5Down Syndrome Medical Interest Group UK. Leeds Community Healthcare NHS Trust
- 6Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
- 7Department of Human Genetics, School of Medicine, Emory University, Atlanta, Georgia, USA
- 8Institute of Psychiatry, Psychology, and Neuroscience, Department of Forensic and Neurodevelopmental Sciences, King’s College London, London, United Kingdom; The London Down Syndrome (LonDownS) Consortium, London, United Kingdom; South London and the Maudsley NHS Foundation Trust
- 9Fondazione Stella Maris IRCCS, Pisa, Italy
- 10Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil
- 11Departments of Pediatrics and of Psychiatry, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
- 12Advocate Medical Group Adult Down Syndrome Center, Park Ridge, IL, USA
- 13Cytogenetics and Genomics Research Unit. Department of Zoology, University of Calcutta.Kolkata. West Bengal, India
- 14Institut Jérôme Lejeune, Paris, France
- 15Department of Developmental Neuroscience, IRCCS Fondazione Stella Maris, Pisa, Italy; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
- 16Pediatric Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
- 17Division of Pediatric Endocrinology, Saarland University Medical Center, Homburg/Saar, Germany
- 18Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany. German Center for Neurodegenerative Diseases, site Munich. Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- 19UCL- Great Ormond Street Institute of Child Health, London, United Kingdom; Whittington NHS Trust, London, United Kingdom; Down Syndrome Medical Interest Group, London, United Kingdom
- ↵**corresponding and senior author: Prof. Monica Lakhanpaul, Population, Policy and Practice Department, UCL GOS Institute of Child Health, +442079052322, m.lakhanpaul{at}ucl.ac.uk
↵* equal contribution
Posted July 02, 2021.
COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey
